Dr. Robert Mignacca joined Children’s Hospital in 1996 and is the medical director of Hematology and acting medical director of Oncology. He has particular expertise in treating patients with sickle cell disease, thalassemia, hemophilia, thrombophilia and rare hematologic disorders. He has a special interest in contributing to the Centers for Disease Control’s ongoing Universal Data Collection project for patients with bleeding disorders, which he has participated in since 2001.

Dr. Mignacca is board certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. In addition to seeing patients, he serves on the clinical faculty of University of California, San Francisco. Dr. Mignacca is a member of the American Academy of Pediatrics, National Hemophilia Foundation and the Children’s Oncology Group. He is also conversant in Spanish.

After graduating from Saint Louis University in Saint Louis, Mo., Dr. Mignacca completed his internship and residency in pediatrics at Children’s Hospital of Los Angeles. He did a fellowship in pediatric hematology/oncology at the University of California, Los Angeles Medical Center.